Contraceptive Counseling

Stepwise guidance for deep and nonpalpable implant removal, the PCOS to PMOS renaming, IUD bleeding patterns in the first 90 days, OCP use and lower-extremity injury risk in athletes, cancer risk data for BRCA1/BRCA2 carriers on hormonal contraception

A store-brand version of Opill is now on shelves at Walgreens and CVS. Here's what providers need to know about this additional over-the-counter contraceptive option.

BV and STI co-infection, iron deficiency anemia trends, ACOG HIV and PrEP guidance, estetrol/drospirenone safety data

Providing supportive, unbiased, and non-judgmental options counseling to patients who feel ambivalent about their pregnancy options.

Patient decision-making around LARC extended use, contraceptive progestogens and meningioma risk, adolescent contraceptive decision-making, residual LNG in the 52mg IUD beyond 8 years

New research on Nexplanon bleeding patterns, contraceptive decision aid quality, TikTok and tubal ligation, post-Dobbs abortion safety beliefs, gender-affirming care gaps, and more.

PCOS renamed polyendocrine metabolic ovarian syndrome, updated ACOG cervical cancer screening guidelines, doxy-PEP losing effectiveness against gonorrhea

A look at some of the narratives that shaped social media conversations about contraception, abortion, and sexual health in the first part of 2026.